Most Critical Documents Supporting Allergan, ValeantMark Melin
You can tell the fight between Allergan, Inc. (NYSE:AGN) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) is coming down to the wire. With a December proxy vote looming, both sides have fought what can only be considered a historic battle.
Some of the key points in the battle are addressed in the to be unredacted confidential documents and emails primarily paint a picture of an intense battle.
ValueWalk . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.